List of References

1. Aihara M, Scardino P T, Truong L D, Wheeler T M, Goad .I R, Yang G, Thompson T C. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer, 1995, 75: 522-529.

2. Aihara M, Truong L D, Dunn J K, Wheeler T M, Scardino P T, Thompson T C. Frequency of apoptotic bodies positively correlates mth Gleason Grade in prostate cancer. Human Pathology., 1994, 25: 797-801.

3 Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson JD. Molecular Biology of the cell. New York: Garland, 1983, 424-6.

4. Albor A, Kaku S and Kulesz-Martin M. Wild type and mutant forms of p53 activate human topoisomerase I. A possible mechanism for gain of function in mutants..Cancer Research 1998; 58, 2091-2094.

5. Alcalde RE, Terakado N, Otsuki K, and Matsumura T. Angiogenesis and expression of platelet derived epidermal cell growth factor in oral squamous cell carcinoma. Oncology. 54: 324-8, 1997.

6. Almog N. Rotter V Involvement of p53 in cell differentiation and development, Biochim. Biophys Acta 1333 (1997) F1-F27.

7. Anneroth G, Smith C. Platz H and Willen R. Correlation between histopathology and behavior. Johnson NW. Risk markers for oral diseases vol 2. oral cancer detection of patients and lesion at risk. Cambridge Univ ersity press, 1991, Cambridge UK ( 57-75))

8. Aotake T, Lu CD, Chiba Y, Muraoka R, Tanigawa N Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis.. Clinical Cancer Research 1999 Jan;5(1):135-42

9. Ashkenazi and Dixit VM. Death receptors: Signalling and modulation. Science. 1998; 281: 1305-1308.

10.Awwad S, Jaros E, Somes J and Lunec J. (1996). p53 overexpression in head and neck carcinoma and radiotherapy results. International Journal of Radiation oncology biology and physics, 34. 323-332.

11.Bartkova J. Lukas J and Muller H. Abnormal patterns of D type cyclin expression and G1 regulation in head and neck cancer. Cancer Research 1995, 55, 949-956.

12.Baserga, R., Oncogenes and the strategy of growth factors. Cell. 1994, 79: 927-930.

13. Bedi A, Pasricha P J, Akhtar A J, Barber J P, Bedi, G C, Giardiello F M, Zehnbauer B A, Hamilton S R, Jones R J. Inhibition of apoptosis during development of colorectal cancer. Cancer Research., 1995, 55: 1811- 1816.

14.Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Le Fur R, Bogaert WV, Caspers R, Glabbeke MV, and Horoit JC. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an intrim report. IJROBP 19, 1449-1453, 1990.

15.Bockmuhl U, Wolf G, Schmidt S, Schwendel A, Jahuke V, Dietel M. Petersen I. Genomic alterations associated with malignancy in head and neck cancer. Head Neck, 1998,20: 145-1 51.

16. Bolger B.S. Symonds R.P, Stanton P.D, MacLean A.B, Burnett R, Kelly P and Cooke T.G. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. British Journal of Cancer 1996, 74: 1223-1226.

17.Bowen ID. Apoptosis or programmed cell death. Cell Biology International 1993; 17: 365-380.

18. Brancolini C, Lazarevic D, Rodriquez J and Schneider. Dismantling cell- cell contacts during apoptosis is coupled to a caspase-dependant proteolytic cleavage of p catenin. Journal of cell Biology. 1997; 139:759- 771.

19. Broders AC, (1941) The microscopic grading of cancer. Surgical clinics of North America, 21, 947-62.

20. Brown J. M and Giaccia A. J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research 1998, 58: 1408-1416.

21. Brown JP and Pagano. Mechanism of p53 degradation Biochimica et Biophysica Acta 1332 (1997) 01-06.

22. Brugal G. Interpretation of proliferation markers. In: Wied GL, Bartels PH, Rosenthal DL, Schenckll. (Editors) . Compendium on the computerized cytology and histology laboratory. 1994. 234-40.

23. Buolamwini JK. Novel anticancer drug discovery. Current Opinion in Chemical Biology 1999 Aug;3(4):500-9

24.Carter R. Pathology of squamous carcinomas of the head and neck. Current opinion in oncology, 1992, 4, 485-490.

25. Chen M, Quintans J. Fuks Z., et. al Suppression of bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, ceramide. Cancer Research 1994, 55: 991-994.

26.Chiesa F, Mauri S, Tradati N, Calabrese L, Guigliano G and Ansarin M. Surfing prognostic factors in head and neck cacner at the millennium. Oral Oncology, 35: 1999, 590-6.

27.Cho Y, Gorina S, Jeffrey PD and Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265: 346-355. 1994.

28. Clayman G L, Lippman S M, Laramore G E, Hong W K. Head and Neck cancer. In : Cancer Medicine (eds: Holland J F, Frei E, Bast R C Jr., Kufe D W, Montoa D L, Weichselbaum R. ), Philadelphia, Williams and Wilkins, 1996, pp 1645-1 709.

29. Coleman C.N. Clinical applications of molecular biology in radiation oncology. Seminars in Radiation Oncology.1996, 6: 245-249.

30. Collins MKL, Perkins GR, Rodriguez-Trduchy G. Nieto MA and Lopez- Rivaz A. Growth factors as survival factors: regulation of apoptosis. Bioessays 1994; 16: 133-138.

3 1 Corvo R, Giaretti W, Geido E, Sanguineti G, Orecchia, Scala M, Garaventa G, Mora E, and Vitale V. Cell kinetics and tumor regression during radiotherapy in head and neck squamous cell carcinomas. International Journal of Cancer, 1996, 68, 151-155.

32.Crocker J, Macartney JC, smith PJ. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. Journal of pathology. 1988. 154: 151-156.

33.Dameron, K.M, Volpert, O.V, Tainsky, M.A and Bouck, N. 'Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1' Science. 1994, 265: 1582-158.

34. De Muricia, Tucco C, Nidergang C, Masson M and de Murica G. Requirements of poly (AD-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci. 1997; 94: 7303-7307.

35. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, et.al. Bcl-2 and Ed-XL antagonize the mitochondria1 dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Research. 1997: 57:62-67.

36. Dewey W.C, Ling C.C and Meyn R.E. Radiation induced apoptosis: Relavance to radiotherapy. Int J Radiat Oncol Biol Phys 1995, 33:781- 796.

37.Ding R and Smulson ME. Depletion of nuclear poly(ADP ribose) polymerase by antisense RNA expression: influence on genomic stability, chromatin organisation and carcinogen cytotoxicity. Cancer Research. 1994: 54: 4627-4634.

38. Dixon S C, Soriano B J, Lush R M, Bomer M M, Figg W D. Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Ann Pharmcother. 1997, 31 : 76-82 .

39. Eguchi Y, Shimizu S and Tsujimoto. lntracellular ATP levels determine cell fate by apoptosis or necrosis. Cancer Research. 1997; 57, 1835- 1840.

40. Ensley JF, Kish JA, Tapazoglou E, Maciorowski Z and Al-Sarraf. The significance of pretreatment Identification of prognostically important subgroups of squamous cell cacners of the head and neck. Hean and neck cacners: Scientific perspectives in management and stratergies for cure. Edited by Jacobs JR, Valeriote FA and Asararof MA. 35- 57Elsevier Science publishers. New York, 1987.

41. Evans T, Rosenthal ET, Youngbloom J, Distel D and Hunt T. Cyclin - a protein specified maternal mRNA in sea urchin eggs that destroyed at the end of each cell cycle. Cell. 33: 389-396. 1983.

42. Field .IK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck, British Journal of Cancer, 1991, 65:573-577.

43. Folkman, J. The role of angiogenesis in tumor growth. Seminars in Cacner Biology. 1992; 3: 65-71

44. Folkman, J. 'Tumor Angiogenesis' Advances in Cancer Research. 1985, 43: 175-203.

45. Franco EL. Multiple cacners of UDAT: the challenge of risk factor identification. Cancer Letters. 1991: 60, 1-8.

46. Friedman A.H, Kolesnick R.N and Fuks 2. Modulation of the apoptotic response: Potential for improving the outcome in clinical radiotherapy. Seminars in Radiation Oncology. 1996, 6: 273-283.

47. Friedman M. Grey P, Venkatesan TK, Bloch I, Chawla P, Caldarelli DD and Coon JS. Prognostic significance of bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 106, 1997. 445-449.

48. Gavreili Y, Sherman Y, Ben-Sasson S A. Identification of programmed cell death in situ via specific labelling of DNA fragmentation. Journal of Cell Biology, 1992, 119: 493-501.

49. Gil-Gomez G, Berns A and Brady HJM. A link between cell cycle and cell death : Bax and Bcl-2 modulate cdk2 activation during thymocyte apoptosis. EMBO 1998;17(24):7209-7218.

5O.Gleich LL, Biddinger PW, Parelic ZP and Gluckman JL. Tumor angiogenesis in T1 oral cavity SCC. Role in predicting tumor aggressiveness. Head & Neck. 1814: 343-346. 1996.

51. Goodger NM, Gannon J, Hunt T and Morgan PR. Cell cycle regulatory proteins-an overview with relation to oral cancer. Oral Oncology, 1997.33:61-73.

52.Gottlieb RA, Nordberg J. Skowronski E and Babior BM. Apoptosis induced in Jurkat cells is preceded by intracellular acidification. Proc. Natl. Acad Sci. 1996; 93: 654-658.

53.Graeber, T. S.. Osmanian, C., Jacks,T., et.al., ' Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumors'. Nature. 1996, 379:88-91.

54. Green DR and Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.

55. Grossfeld G.D, Ginsberg, D.A, Stein, J.P, et.al., 'Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression'. Journal of National Cancer Institute. 1997, 89:219-227.

56. Hagedorn HG, Tubel J, Wiest I, Nerlich In situ apoptotic and proliferation index in laryngeal squamous cell carcinomas. Annals of Cell Pathology 1998;16(3):177-84

57. Haimovitz-Friedman A. Kolesnick RN and Fuks Z. Modulation of the apoptotic response: potential for improving the outcome in clinical radiotherapy. Seminars in Radiation Oncology. 1996; 6:273-283.

58. Hallahan D.E. Radiation mediated gene expression in the pathogenesis of clinical radiation response. Seminars in Radiation Oncology 1996. 6: 250-267.

59. Hanahan, D., and Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis . Cell. 1996, 86: 353-364.

60. Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997; 89: 1 845-1 853.

61. Hansen R and Oren M, p53-from inductive signal to cellular effect, Current Opinions in Genetics and Development 7 (1 997) 46-51

62. Harn HJ, Hsieh HF, Ho LI, Yu CP, Chen JH, Chiu CC, Fan HC, Lee WH Apoptosis in nasopharyngeal carcinoma as related to histopathological characteristics and clinical stage. Histopathology 1998 Aug;33(2): 11 7- 22

63. Harris C, Hollstein M (1993) New England Journal of Medicine 329, 1318-1327.

64. Harris CC. The 1995 Walter Hubert lecture-molecular epidemology of human cancer: insights from the mutational analysis of p53 tumor suppressor gene. British Journal of Cancer. 73, 1996, 261-267

65. Hartwell LH and Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989, 246, 629-633.

66.Haupt Y, Maya R, Kazak A, Oren M, MDM-2 promotes the rapid degradation of p53, Nature 387 (1997) 296-299.

67.Hayatsun Y, Matsumura K, Tsuji T, lnowe T, Morimoto H and Shinozaki F. Study on the NORs associated protein (AgNOR) in OSCC and benign lesions. Japanese Journal of Oral Maxillofacial Surgery. 1992: 381891-895.

68.He H, Lam M, Tomas S, McCormick and Clark W. Maintenance of calcium homeostasis in the endoplasmic reticulum by bcl-2. Journal of Cell Biology. 1997; 138, 1219-1228.

69. Heedt BG, Houston MA, Anthony GM and Augenlicht LH. Mitochondria1 membrane potential (Awmt) in the coordination of p53 independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Research. 1998; 58, 2869-2875.

70. Henzel P A, Balaram P, Bernarard H. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. International Joumal of Cancer, 1996, 68: 1-4.

71. Herrnanek P and Sobin LH. TNM classification of malignant tumors. International Union Against Cancer. (UICC): 4m Edition, Berlin. Springer 1992.

72.Hieken TJ, Das-Gupta TK. Mutant p53 expression: a marker of diminished survival in well differentiated soft tissue sarcoma. Clinical Cancer Research. 1996; 2(8):1391-1395.

73.Hirooka Y, Hamazoe R and Shiota S. AgNORs as a predictor of hepatic recurrencein colorectal cancer-assessment of cytological material obtained by endoscopic biopsy. Japanese Journal of Caner Clinics. 1994: 40. 1595-9.

74.Holash J, Wiegand SJ, Yancopoulos GD New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999 Sep 20;18(38):5356-62

75.Holmgren, L., O'Reilly, M. S and Folkman, J., Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine. 1995, 1: 149-153.

76.lzawa H, Yonemitsu N, Shin T, Sugihara H. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Auris Nasus Larynx 1999 Ju1;26(3):317-30

77.Jackel MC, Dorudian MA, Maoc D, Brinck U, Schauer A, Steiner W. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 1999 Feb 1 ;85(3):591-9

78. Jacobs JR. Valeriote FA and Asararof MA. The significance of pretreatment identification of prognostically important subgroups of squamous cell cancers of head and neck. In: Head and neck cancers: scientific perspectives in management and strategies for cure, pp. 35- 56. Elsevier Science Publishers. New York 1987.

79. Jacobson MD. Apoptosis: Bcl-2 related proteins get connected. Current Biology. 1997; 7: R277-R281.

8O.Jiang W, Kahn SM , Zhou P, Cacace AM, Infante AS, Doi S, Santella RM and Weinstein IB. Over-expression of cyclin D l in rat fibroblast causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene. 811 2: 3447-3487. 1993.

81. Johnson NW. Risk markers for oral diseases vol 2. oral cancer detection of patients and lesion at risk. Cambridge University press, 1991, Cambridge UK

82. Jordan RCK, Catzavelos GC, Barrett AW and Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncology, 32B, 6, 394-400, 1996.

83. Kerr J F R, Wyllie A H, Currie A R. Apoptosis : a basic biological phenomenon with wide ranging implications in tissue kinetics. British Journal of Cancer, 1992, 26: 239-257.

84. Kesari A L, Chellam V G, Nair P P, Madhavan J, Nair M K, Pillai M R. Expression of the anti apoptotic protein bcl-2 is not dependent on the tumor suppressor protein p53 in Indian breast carcinoma. Pathobiology., 1997, 65: 108-1 12.

85.Kin MB, Toth K, Cao S, Guo B, Frank C, Slocum HK, Rustum YM. Involvement of cyclin Dl-cdk5 overexpression and MCM3 cleavage in bax-associated spontaneous apoptosis and differentiation in an A253 human head and neck carcinoma xenograft model. International Journal of Cancer 1999 Oct 29;83(3):341-8

86. Kirita T, Ohgi K, Shimooka H, Yamamaka Y, tatebayashi S, Yamamoto K, Mishima K and Sugimura M. Pre-opertaive concurrent chemoradiotherapy plus radical surgery for advanced SCC of the oral cavity. An analysis of long term results. oral Oncology. 1999, 35: 597- 606.

87. Knudson CM and Korsmeyer SJ. Bcl-2 and Bax function independently to regulate cell death. Nature Genetics. 1997; 16: 358- 363.

88. Koh JY, Cho NP, Kong G, Lee JD, Yoon K p53 mutations and human papillomavirus DNA in oral squamous cellcarcinoma: correlation with apoptosis. British Journal of Cancer 1998 Aug;78(3):354-9

89. Kohn, E.C. 'Invasion and metastasis: Biology and dinical potential'. Pharmacological Therapeutics. 1991, 52:235-244.

90. Kondo T, Takeuchi K, Doi Y, Yonemura S, Nagata S Tsukita, et.al. ERM (EzrinlRadixinlMaerin) based molecular mechanism of microvillar breakdown at an early stage of apoptosis. Journal of Cell Biology. 1997; 139:749-758.

91. Koshida Y, Saegusa M, Okayasu I. Apoptosis, cell proliferation and expression of bcl-2 and bax in gastric carcinomas : immunohistochemical and clinicopathological study. British Journal of Cancer, 1997, 75(3): 367-373.

92. Kotelnikov VM, Coon JS 4th, Mundle S, Kelanic S, LaFollette S, Taylor S IV, Hutchinson J, Panje W, Caldarelli DD, Preisler HD Cyclin D l expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clinical Cancer Research. 1997 Jan;3(1):95-101

93.Kropveld A, Van-Mansfeld ADM, Nabben N, Horijk GJ and Slootweg PJ. (1996) Discordance of p53 status in matched primary tumors and metastases in head and neck squamous cell carcinoma patients. Oral Oncology, 32, 388-393.

94. La Vecchia C, Tavani A, Levi F, Frarceschi S, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncology, 1997, 33:302-312.

95. Lane D and Crawford L. T antigen is bound to a host protein in SV40 transformed cells, Nature 278 (1979) 261-263.

96. Lavoie JN, Nguyen M. Marcellus RC, Branton PE and Shore GE. E4orf4, a novel adenovirus death factor that induces p53 independent apoptosis by a pathway that is not inhibited by zVAD-fmk. Journal of Cell Biology. 1998; 140: 637-645.

97. Lee J.M and Bernstein. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993, 90: 5742-5746.

98. Levine AJ, p53, the cellular gate keeper fro growth and division, cell 88 (1 997) 323-331.

99. Lewensohn-Fuchs I, Munck-wikland E, Berke Z, Magnusson K P, Pallesen G, Auer G, Lindholm J. Involvement of abberant p53 expression and HPV in carcinoma of head, neck and esophagus. Anticancer Research. 199414: 1281-6

100. Lingen MW. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents. Critical Reviews in Oral Biology & Medicine 1999; lO(2): 153-64

101. Linzer DIH and Levine AJ, Charecterisation of a 54Kd cellular SV40 tumor antigen' present in SV40 transformed cells and ininfected embryo carcinoma cells. Cell 17 (1979) 43-52.

102. Lippman SM and Hog WK. Second malignant tumors in head and neck SCC: the overshadowing threat for patients with early stage disease. International J of Radiation Oncology Biology Physiology. 1989: 17: 691-4.

103. Lipton J, Leizel K, Carney W, Lowder J et.al. Elevated mutant p53 levels in breast cancer cytosols. Proceedings of Annual Meeting of American Association for Cancer Research. 1993; 34: A1 163.

104. Liu X and Wang X. Induction of apoptotic programme in cell free extracts: requirement for dATP, and cytochrome C. Cell 1996; 86, 147-157.

105. Liu X, Li P, Widlak P, Zou H. Luo X, Garrard, et.al. The 40 kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci.1998; 95: 8461-8466.

106. Lu C and Tanigawa N. spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer research. 57, 221-224 (1997)

107. Maeda K, Chung Y. S, Takatsuka S, Ogawa Y, Onoda N, Sowa M. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. British Journal of Cancer 1995, 72, 319-323.

108. Marchetti P, Castedo M, Susin SA, et.al. Mitochondria1 permeability transition is a central co-ordinating event of apoptosis. Journal of Experimental Medicine. 1996; 184, 11 55-1 160.

109. Marzo I, Bremer C, Zamzami N, Jugensmeier JM, Susin SA, Vleira HLA, et.al. Bax and adenine nucleotide translocator co operate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-2031.

110. Maxwell P.H, Dachs G.U, Gleadle J.M, Nicholls L.G, Hanis A.L, Stratford I.J, Hankinson 0 , Pugh C.W and Ratcliffe P.J. Hypoxia-inducible factor modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci 1997, 94: 8104-8109.

11 1. Mehta FS, Hamner JE. Tobacco-related oral mucosal lesions and conditions in India. Basic dental research unit, TIFR, Bombay 1993 edition 107-108.

112. Meijerink JP, Mensink EJ, Wang K, et.al.' Hematopoietic malignancies demonstrate loss-of-function mutations of bax. Blood 1998; 91: 2991-2997.

113. Meritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lowe DP, et.al. The role of p53 in spontaneous and radiation induced apoptosis in gastrointestinal tract of normal and p53 deficient mice. Cancer Research. 1994; 52: 5407-541 1.

114. Merrit AJ, Jones LS and Potten CS (1996) Apoptosis in murine intestinal crypts. In techniques in Apoptosis, T Cotter ad S. Martin (eds) 269-299.

115. Merritt AJ, Potten CS, Kemp CJ, Hickman AJ, Balmain A, Lane DP, and Hall PA. The role of p53 in spontaneous and radiation induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice. Cancer Research 54, 614-617, 1994.

116. Michalidies R, Van Veelan N, Hart A, Loftus B, Weintjens E and Balm A. Overexpression of cyclin D l correlates with recurence in a group of 47 operable squamous cell carcinomas of the head and neck. Cancer Research. 55, 975-978 91995)

117. Mills JC, Stone NL, Erhardt J and Pittman RN. Apoptotic membrane blebbing is regulated by myosin light phosphorylation. Journal of Cell Biology. 1998; 140: 627-636.

118. Miyashita T, Reed J C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 1995, 80: 293-299.

119. Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E lmmunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 1997, 33(5):369-74

120. Munirajan A K, lshi Y T, Mohanprasad B K C, Hirano Y, Munakata N, Shanmugham G, Tsuchida N. p53 gene mutations in oral carcinomas from India. International Journal of Cancer, 1996, 66: 297-300.

121. Munro R. Chapter 3. Principles of radiotherapy and chemotherapy. Management of oral cancer. Ed. Stafford N and Waldron Oxford University Press. 1989. UK. Pg-269

122. Murray A. Cell cycle check points. Current opinions in cell biology. 1994, 6, 872-86.

123. Nagami H, Tamura K and Kin S. Evaluation of malignant potential by AgNOR staining in gastric cancer. Japanese Journal of Cancer Clinic. 1994:40. 161 1-4.

124. Nair MK, Sankarnarayanan R, Padmanbhan TK, Evaluation of the role of radiotherapy in the management ofcarcinoma of the buccal mucosa. Cancer 61 , 1988, 1326-1331.

125. Naito M, Nagashima K, Mashima T and Tsuruo T. Phosphatidylserine externalisation a downstream event of IL 1p converting enzyme family protease activation during apoptosis. Blood 1997; 89:2060-2066.

126. Ngan BY, Chen Levy Z, Weiss LM, Warnke RD and Cleary M. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with t(14:18) chromosomal translocation. New England Journal of Medicine. 1988; 318: 1638-1644.

127. Ohbu M, Saegusa M. Okayasu I Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types.. Virchows Arch 1995;427(3):271-6

128. Padmanabhan TK, Sankaranarayanan R and Nair MK. Evaluation of local control, survival and pattern of failure with radiotherapy in cancer of the tongue. 1990, Oncology 47: 121-123.

129. Pai SI, Wu GS, Ozoren N, Li W, Jen J, Sidransky D, et.al. Rare loss-of- function mutation of a death receptor gene in head and neck cancer. Cancer Research. 1998; 58: 3513-351 8.

130. Paterson IC. Eveson JW and Prime SS. molecular changes in oral cancer may reflect aetiology and ethnic origin. Oral oncology 32b. 1996, 1 50-1 53.

131. Pepper C and Hoy T and Bently. Bcl-21Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. British Journal of Cancer, 1997, 76, 935-938.

132. Piftko J, Bankfalui A, Torg K, Fuzesi L, Bryne M, Ofmer D, Kusch F, Joos U, Schmid K W. Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas. Head Neck, 1998, 20: 8- 15.

133. Piffko J. Bankfalvi A and Ofner D. Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumor front of oral SCC. British Journal of Cancer. 1997, 75, 1543-6.

134. Piffko J, Bankfalvi A, Ofner D, Rasch D, Joosu U, Schimid KW. Standardised AgNOR analysis of the invasive tumor front in oral SCC. Journal of Pathology, 1997: 182, 450-6.

135. Pillai MR, Jayaprakash PG, Nair MK. Bcl-2 immunoreactivity but not p53 accumulation associated with tumor response to radiotherapy in cervical carcinoma. Journal of Cancer Research and Clinical Oncology. 1999; 125155-60.

136. P~ndborg JJ, Reichart PA, Smith CJ and Waal IVD. Histological typing of cancer and precancer of the oral mucosa in collobration with LH Sobin and pathologists in nine countries. WHO. Berlin. Springer. 1997.

137. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F and Adnet JJ. Improvement in the staining and visualization of the argyrophilic proteins of the NOR at the optical level. Histochemical Journal. 1986. 18: 5-14.

138. Polyak K. Xia Y, Zweier JL, Kinzier KW and Vogelstein B. A model for p53 induce apoptosis. Nature 1997; 389: 300-305.

139. Potten CS. What is an apoptotic index measuring? A commentary. British Journal of Cancer 1996, 74, 1743-1748.

140. Rampino N. Yamamoto H, lonov Y, Li Y, Sawai H and Reed JC, et.al. Somatic frameshift mutations in the bax gene in colon cancers of the microsatellite mutator phenotype. Science 1997; 275: 967-969.

141. Rao I, White E. Bcl-2 and the ICE family of apoptotic regulations making a connection. Current Opinions Genetic and Development., 1997: 52-58.

142. Ravi D, Nalinakumari K R, Rajaram R S, Nair M K, Pillai M R. Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Letters., 1996, 105: 139-146.

143. Ravi D, Ramadas K, Mathew BS, Nalinakumari KR, Nair MK and Pillai MR. (1998) Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol~gy, 34, 543-548.

144. Ravi.D, Ramdas.K, Mathew B.S, Nalinakumari K.R, Nair M.K, Pillai M.R. 'De novo programmed cell death in oral cancel'. Histopathology 34 (1999) 241-249.

145. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA and Tetu B. (1 997) Markers of radioresistance in squamous cell carcinomas of head and neck: a clinicopathologic and immunohistochernical study. Journal Clinical Oncology, 15, 1030-1 038.

146. Raybaud-Diogene H, Tetu B, Morency R, Fortin A and Monteil RA. (1996). p53 overexpression in head and neck squamous cell carcinoma: Review of literature. Oral Oncology, 32, 143-149.

147. Reed JC. Dysregulation of apoptosis in'cancer. Journal of Clinical Oncology. 17: 2941-53. 1999.

148. Robineau G, Kappas C, Diot L, Rosenwald JC AVSIexpress for the PC implementation of a 3D visualization module for radiotherapy. Computer Methods Programs Biomed 2000 Feb;61(2):111-8

749. Rupnow BA, Murtha AD, Alarcon RM, Giaccia AJ, Knox SJ. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Cancer Research 58 ,1998. 1779-1784.

150. Russell NS, and Bartelink H. Optimized radiotherapy for head and neck cancer. Current opinion in Oncology 1992, 4, 491-498.

151. Sankaranarayanan R, Nair M K, Mathew B, Balaram P, Sebastian P, Dutt S C. Recent results in oral cancer research in Kerala. Head Neck, 1992 14: 107-1 12.

152. Schwint AE, Savino TM, Lanfranchi HE, Marschoff E, Cabrini RL and Hoiz ME. NORs in lining epithelium adjacent to SCC of human oral mucosa. Cancer. 1994:73, 2674.

153. Shaw, B. W., Bowley, T. and Tanders, S. 'Induction of apoptosis by wild type p53 in a human colon tumor derived cell line'. Proceedings of National Academy of Sciences. USA. 1992, 89, 4995-4999.

154. Sheets EE. Crum CP and Yeh J. Association between cervical neoplasia and apoptosis as detected by nuclear labeling. Gynecology Oncology. 63: 94-1 00, 1996.

155. Sidransky D and Hollstein M. (1996) Clinical implications of the p53 gene. Annual Review of Medicine, 47, 285-301.

156. Smith C, Pindborg JJ and Binnie WH (1990) Oral cancer Epidemiology, etiology and pathology. Hemisphere publishing corporation USA. Pg 10.

157. Smulson ME, Pang D, Jung M, Dimtchev A, Chasovskikh S, Spoonde A, et.al. Irreversible binding of poly ADP ribose polymerase cleavage products to DNA ends revealed by atomic force microscopy: possible role in apoptosis. Cancer Research. 1998; 58, 3495-3498.

158. Spiro RH, Huvos AG, Wong Gy, Spiro JD, Gnecco CA and Strong EW. (1986) predictive value of tumor thickness in squamous cell carcinoma confined to the tongue and floor of the mouth. American Journal of Surgery, 152, 345-50.

159. Srinivas G, Kusumakumari P, Nair M K, Panicker K R, Pillai M R. Bcl-2 proein and apoptosis in pediatric acute lymphoblastic leukemia. International Journal of Molecular Medicine, 1998, 1: 765-769.

160. Srinivas G, Kusumakumary D, Nair MK, Panicker KR and Pillai MR. (2000) Mutant p53 protein, Bcl-2IBax ratios and apoptosis in pediatric acute lymphoblastic leukaemia. Journal of Cancer Research and Clinical Oncology, 126,62-67.

161. Stafford N and Waldron. Chapter 3. Munro. R., Principles of radiotherapy and chemotherapy. Managenment of oral cancer. Ed. Oxford University Press. 1989. UK. Pg-269.

162. Stahl A. The nucleolar and nucleolar chromosomes. In: The Nucleolus. Cambridge. Cambridge university Press. 1982: 1-24.

163. Stephens L. C, Ang K. K, Schultheiss T. E, et al., Apoptosis in irradiated murine tumors. Radiation Research 1991, 127: 308-316.

164. Stewart, B. W. Mechanisms of apoptosis : integration of genetic, biochemical and cellular indicators. Journal of National Cancer Institute. 1994, 86: 1286-1296.

165. Stich HF, Rosin MP, Hornby AP, Mathew B, Sankaranarayanan R and Nair MK. Remission of oral leukoplakias and micronuclei in tobacco betel quid chewers treated with beta-carotene and with beta carotene plus vitamin A. International Journal of Cancer. 42, 195-199. 1988.

166. Suda T, Takakura N, Oike Y Hematopoiesis and angiogenesis. International Journal of Hematology 2000 Feb;71(2):99-107

167. Susin SA, Zamzami N, Caskedo M, Hirsch T, Marchetti, Macho A, et.al. Bcl-2 inhibits the mitochondria1 release of an apoptogenic protease. J Experimental Medicine. 1996; 184: 1331-1 342.

168. Tada M, Matsumoto R, lggo R. D, Onimaru R, Shirato H, Sawamura Y and Shinoha Y. Selective sensitivity to radiation of cerebral glioblastomas harbouring p53 mutations. Cancer Research 1998, 58: 1793-1797.

169. Thornberry NA and Lazebnik. Caspases: Enemies within. Science. 1998; 281: 1312-1316.

170. Tipoe GL, Jin Y and White FH. The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium. Oral Ooncology 328, 24-31, 1996.

171. Urist MM. O'Brien CJ, Soong SJ, Vischer DW and Maddox A (1987) Squamous cell carcinoma of buccal mucosa: analysis of prognostic factors. American journal of surgery, 154, 41 1-14

172. Vikram B, Strong E, Shah JP and Spiro. (1'984a). Failure at the primary site following multimodality treatment for advanced head and neck cancer. Head and neck surgery. 6, 720-3.

173. Vindigni, C., Miracco, C.. Spina, D., et.al., 'Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of Intestinal type. International Journal of Cancer (Predictive Oncology). 1997, 74:637-641.

174. Vogelstein B, Fearon E and ha milt on.^, (1988) NEJM 319, 525-532. 175. Wang TH, Wang p53, apoptosis and human cancers. HSJ Formos Med

ASSOC 1996 Ju1;95(7):509-22

176. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J., Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine. 1991, 324: 1-8.

177. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD, et.al. Constitutive expression of the machinary for programmed cell death. Journal of Cell Biology. 1996; 133: 1053-1059.

178. WHO Collaborating Centre For Oral Precancerous Lesions(l978) Definition of leukoplakia and related lesions: an aid to studies on oral pre- cancer. Oral Surgery., 46,518-539.

179. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S and Jurkiewiu MJ. American Journal of Surgery. 16815: 373-380. 1994.

180. Willner J, Baier K, Pfreundner L, Flentje M Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncologica 1999;38(8): 1025-30

181. Wolter KG, Hsu Y, Smith CL, Nechustan A, Xi X and Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. Journal of Cell Biology. 1997; 139, 1281-1292.

182. Wu GS, Bums TF, McDonald ER, Jiang W, Meng R, Krantz ID, et.al. KillerlDR5 is a DNA damage inducible p53 regulated death receptor gene. Nature Genetics 1997; 17: 141-143.

183. Wyllie A. Clues in the p53 murder mystery. Nature. 1997; 389: 237-238.

184. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer metastasis review. 1992; 1 1 :95 103.

185. Xie X, Clausen OPF, Sudbo J and Boysen M. Diagnostic and prognostic value of nors in normal epithelium, dysplasia and SCC of the oral cavity. Cancer. !997: 79, 2200-8.

186. Yamamoto Y. Hoh T, Saka T, Makimoto K and Takahashi H. Assessment of proliferative activity in thyroid tumors by AgNOR staining and cytoflurometry. Japanese Journal of Head and Neck Cancers. 1993: 19, 285-8.

187. Yamasaki L, Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2FIDP action. Biochimica et Biophysica Acta 1423 (1 999) M9-MI 5.

188. Yang J, Liu X, Bhalla K, Kim CN, lbrado AM, Cai J, et.al. Prevention of apoptosis by Bcl-2: Release of cytochrome C from mitochondria blocked. Science 1997; 275: 1 129-1 132.

189. Yano G, Nakashima T and Nomura Y. Prognostic significance of AgNOR in carcinomas of the larynx and hypopharynx. Japanese Journal of Larynx. 1995. 7:31-34.

190. Yue L, lwai I and Furuta I. Evaluation of AgNOR in tongue SCC. Oral Oncology. 35:1999, 70-76.

191. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Montemey I, Castedo M and Kroemer G. Mitochondria1 control of nuclear apoptosis. J Exp. Med. 1996; 183: 1533-1 544.

192. Zanke BW, Lee C, Arab S and Tannock IF. Death of tumor cells after intracellular acidification is dependant on stress-activated protein kinases (SAPKIJNK) pathway activation and cannot be inhibited by bcl-2 expression

or Interleukin 1P converting enzyme inhibition. Cancer Research. 1998; 58: 2801-2808.

193. Zhan Q, Fan S, Bae I et.al., Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994, 9: 3743-3751.

RELEVANT PUB1,ICATIONS

1. D.Ravi, K.R.Nalinakumari, R.S.Rajaram, MKrishnan Nau, M.R.Pillai. 'Expression of Programmed cell death regulatory p53 and bcl-2 proteins in oral cancer'. Cancer Letters 105 (1996) 139.146.

2. M.R.Pillai, D.Ravi and M.K.Nair.' Chemoprevention of oral cancer: the need for effective biological monitoring'. Singapore Dental Journal 22 (1997). (Review)

3. D.Ravi, K.Ramdas, B.S.Mathew, K.R.Nalinakumari, M.K Nau, M.R. Pillai. 'De novo programmed cell death in oral cancer'. Histopathology 34 (1999) 241 -249.

4. D.Ravi, K.Ramdas, B.S.Mathew, K.R.Nal'mak~unari M.K.Nair and M.R.Pillai. 'Angiogenesis during tumor progression 111 the oral cavity is related to reduced apoptosis and high tumor cell proliferation'. Oral Oncology 34 (1998) 543-548.

5. MR.PiUai, K.Ramdas, K.R.Nalinakumari D.Ravi and M.K.Nair. 'Cellular manifestations of tumor progression in the oral mucosa: Role of human papillomavirus, apoptosis, angiogenesis, proliferation and tumor associated genes p53, bcl-2 and bax. Oral Oncology Vol VI Proceedings of the 6th International Congress on Oral Cancer. (1999) 51-54.

6. D.Ravi, K R Panikkar, K.Ramdas, M.K Nair and M.R. P~llai. Prognostic significance of p53 expression in oral cancer. Proceedings of 1 2 ~ Kerala Science congress, Jan-2000.

7. D.Ravi, K.R Panickkar, M.K. Nair and M.R. Pillai. ' Apoptosis: insights on future directions in cancer therapy' (Review)National Medical Journal of India. (2000), 13.71- 78.

8. D.Ravi, K.Ramdas, B.S.Mathew, K . R . N a l i i r i , K.R.Panikkar, M.K.Nair and M.R.PiUai. Mutant p53 Protein: Prognostic significance in oral cancer. (2000) (Communicated)

9. D.Ravi, K.Randas, B.S.Mathew, K.R.Nalinakumari, K.R.Panikkar, M.K.Nair and M.R.Pillai. Apoptosis, angiogenesis and proliferation: trifunctional roles in tumor response to radiotherapy for oral cancer. (2000) (Communicated)

10. D.Ravi, K.Ramdas, K.R.Pamkkar, M.K.Nair and M.R.Pillai 'Angiogenesis and apoptosis in the prediction of radiotherapy response in oral cancer' in 'Radiobiology - 2000' International conference on Radiobiology Feb 17-19, held at Trivandnun. (AR Gopal Ayenkar award for BEST POSTER presentation)